Organisation paid for research Program year 2025 Source: CMS Open Payments

Johnson Dermatology Clinic

Neither a doctor nor a teaching hospital

Research payments

$1,627,480

124 payments

Through program year 2025, Johnson Dermatology Clinic is reported as receiving $1,627,480 in research payments, across 124 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $53,176 12
2024 Research $390,904 17
2023 Research $179,493 3
2022 Research $147,547 5
2021 Research $454,291 15
2020 Research $285,114 48
2019 Research $116,955 24

Breakdown

Who paid Research payments · program years 2019–2025
  1. Amgen Inc. $1,272,738 43 payments
  2. LEO Pharma AS $219,278 51 payments
  3. AbbVie, Inc. $122,378 27 payments
  4. Galderma Research & Development, LLC $11,411 2 payments
  5. Celgene Corporation $1,674 1 payment
Studies the money was for Research payments · program years 2019–2025
  1. PPSO-004/20200057 (SPROUT Rollover) $204,267 2 payments
  2. Ppso-003/20200056 (Sprout) $175,762 2 payments
  3. Ph3 Otezla in Peds mild/mod PsO PMR $168,460 2 payments
  4. Ph3b Otezla in Peds mod/sev PsO (SPROUT rollover) $165,712 3 payments
  5. Ph3b Otezla in Peds mod/sev PsO SPROUT rollover $161,375 1 payment
  6. Efficacy/Safety Study of Apremilast in Pedi Subjects With Moderate to Severe Plaque PSO (PPSO-003) $158,849 23 payments
  7. Long-Term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - Ecztend $112,396 26 payments
  8. Ph3 Otezla in Peds mod/sev PsO (SPROUT) $109,596 3 payments
  9. A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata (Up-AA) $92,846 21 payments
  10. Efficacy/Safety study of Apremilast in subjects with Mild-to-moderate Plaque Psoriasis (PSOR-022) $83,523 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record